医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SKIA Develops SKIA_Breast, AR Navigation on Patient Body for Doctors

2022年05月09日 PM10:00
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

SKIA Co., Ltd. (CEO Lee Jong-Myung) has introduced an innovative technology that will lead to an evolution in surgical preparations and take procedures one step further.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220509005059/en/

SKIA_Breast is a digital surgery guide solution based on augmented reality (AR) that superimposes a patient’s medical images (like CT or MRI) with a real-time camera view of the surgeon. The surgeon can check the location or shape of tissue by examining an image which is projected onto the patient’s skin which could not normally be seen with the naked eye. Without having to visualize a two-dimensional image on the monitor as three-dimensional, the surgeon can concentrate more on the operation. Therefore, the accuracy and stability of the procedure are greatly improved.

For any successful surgery, it is very important to accurately capture the location and size of a lesion and to be able to reach the lesion by causing as little injury to the surrounding tissues as possible. This is one reason why a surgeon’s experience and the sensitivity and control in their fingertips have long been considered more important than anything else, despite the introduction of various cutting-edge diagnostic equipment or robots.

SKIA_Breast consists only of a tablet and a case with a 3D sensor, making it portable and easy to use. In addition, there is no need for a workstation with various sensors that are large and sensitive to shock or vibration.

SKIA_Breast can see through the human body, so it helps to reduce any deviation of skill level according to surgical experience. Additionally, for patients, radiation exposure from CT scans may be reduced. It can also replace wire localization, which is for patients with small lesions that cannot be identified by touch.

The biggest strength of the SKIA_Breast is that it is “markerless”. Most current AR technologies applied in surgery need multiple markers to be physically implanted in bone tissue such as the spine or skull. Since SKIA_Breast uses no markers, additional procedures to implant markers are not required. Moreover, through its further development, it can be used for education, patient explanation, and additional surgeries.

SKIA Co., Ltd. is a medical extended reality software development startup which was established on September 1, 2018. The company released a patent for a medical image augmented reality system in Korea in October 2019. Also in September 2020, they successfully registered a patent in the USA (US 10803608 B1). In October 2021, they won the Johnson & Johnson QuickFire Challenge 2021. Currently, SKIA_Breast is in a clinical trial phase with Ewha Womans University Hospital.

Lee Jong-Myung, the CEO of SKIA, said, “We are also working with other hospitals to expand application of our solution to procedures such as facial reconstruction and lithotripsy. In the future, we will develop a solution that can be applied to other organs such as liver and pancreas.”

View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005059/en/

CONTACT

SKIA

Lee Jong-Myung

+82-2-6953-1502

hr@skia.kr

同じカテゴリーの記事 

  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024